Koyfin Home > Directory > Health Care > LA Jolla Pharma > Cost of Goods Sold

LA Jolla Pharma Cost of Goods Sold Chart (LJPC)

LA Jolla Pharma annual/quarterly Cost of Goods Sold from 2014 to 2020.
  • LA Jolla Pharma Cost of Goods Sold for the quarter ending September 09, 2020 was $1m a 39.60% increase of 1m year over year
  • LA Jolla Pharma Cost of Goods Sold for the last 12 months ending September 09, 2020 was $4m a 33.81% increase of 1m year over year
  • LA Jolla Pharma Annual Cost of Goods Sold for 2019 was $2m a 31.31% increase of 1m from 2018
  • LA Jolla Pharma Annual Cost of Goods Sold for 2018 was $2m a -5,047.60% decrease of -83m from 2017
  • LA Jolla Pharma Annual Cost of Goods Sold for 2017 was $85m a 26.35% increase of 22m from 2016
Other Income Statement Metrics:
  • LA Jolla Pharma EBITDA for the quarter ending December 12, 2018 was $-42m a -17.59% increase of 7m year over year
  • LA Jolla Pharma Net Income for the quarter ending December 12, 2018 was $-45m a -11.25% increase of 5m year over year
  • LA Jolla Pharma Total Revenue for the quarter ending September 09, 2018 was $3m a 97.55% increase of 3m year over year
View Chart On Koyfin

Quarterly LJPC Cost of Goods Sold Data

09/2020$1m
06/2020$1m
03/2020$1m
12/2019$1m
09/2019$1m
06/2019$1m
03/2019$1m
12/2018$1m
09/2018$0m
06/2018$31m

Annual LJPC Cost of Goods Sold Data

2019$2m
2018$2m
2017$85m
2016$62m
2015$29m
2014$10m
2013$4m